PRTA

PROTHENA CORP PUBLIC LTD CO

Nasdaq · Pharmaceutical Preparations · Inc. L2 · CIK 0001559053
$9.14 -2.25% $489.5M
High Impact Filing (8/10)
Vol
Market Cap$489.5M
Cap SizeSmall Cap
Analyst ConsensusBuy (67%)
SEC Reports4
Exchange Nasdaq·Sector Pharmaceutical Preparations·Inc. L2·CIK 0001559053·Prev Close $9.35

Recent Activity

May 15, 2026 Insider
COLLIER RICHARD T sold 27,000 shares
Director @ $0.00 ($0.00)
May 15, 2026 Insider
Dunn William H. Jr. sold 27,000 shares
Director @ $0.00 ($0.00)
May 15, 2026 Insider
Ekman Lars sold 27,000 shares
Director @ $0.00 ($0.00)
May 14, 2026 SEC
William P. Scully filed a Form 3 initial statement of beneficial ownership, disclosing 736,000 ordinary shares held dire
3 — Impact 2/10
May 13, 2026 earnings_calendar
PRTA Q1 2026 Earnings Scheduled — 2026-05-13
May 7, 2026 SEC
Prothena reported a transformative Q1 2026: net income of $32.7M (diluted EPS $0.60) vs. consensus loss of -$0.31, drive
8-K — Impact 8/10
Mar 27, 2026 SEC
Prothena Corp PLC is holding its 2026 Annual General Meeting to elect two directors and vote on non-binding resolutions
DEFA14A — Impact 3/10

Price Targets

$21.40 +134.1% upside Strong Buy
Current $9.14 Low $8.00 Median $20.00 High $36.00 5 analysts
$8.00 $36.00

Analyst Ratings

Buy67% buy · 12 analysts
2Strong Buy
6Buy
3Hold
1Sell
0Strong Sell
Recent Analyst Actions
DateFirmActionRating
May 8, 2026 Citizens MAINTAIN Market Outperform → Market Outperform
Feb 20, 2026 RBC Capital MAINTAIN Sector Perform → Sector Perform
Dec 1, 2025 Citizens MAINTAIN Market Outperform → Market Outperform

Earnings Estimates

PeriodEPS Est.RangeGrowth#
Current Q $0.38 ▼ -71.3% $-0.38 — $1.14 122% YoY 2
Next Q $-0.30 ▼ -13.2% $-0.37 — $-0.23 55% YoY 2
Current FY $0.05 ▼ -92.2% $-0.55 — $0.65 101% YoY 2
Next FY $-1.31 ▼ -26.0% $-1.31 — $-1.31 -2720% YoY 1

Recent Insider Trades

DateInsiderTypeValue
May 15, 2026COLLIER RICHARDA$0.00
May 15, 2026Dunn WilliamA$0.00
May 15, 2026Ekman LarsA$0.00
May 15, 2026Cooke ShaneA$0.00
May 15, 2026Selkoe DennisA$0.00

No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.

14 unique insiders with 0 transactions. Net insider value: $0.00 ($0.00 bought, $0.00 sold).

Insider Transactions

DateInsiderTitleTypeSharesPriceValue
May 15, 2026COLLIER RICHARD TDirectorA27,000$0.00$0.00
May 15, 2026Dunn William H. Jr.DirectorA27,000$0.00$0.00
May 15, 2026Ekman LarsDirectorA27,000$0.00$0.00
May 15, 2026Cooke ShaneDirectorA27,000$0.00$0.00
May 15, 2026Selkoe Dennis J.DirectorA27,000$0.00$0.00
May 15, 2026WELCH DANIEL GDirectorA27,000$0.00$0.00
Apr 10, 2026Kingston Anne EvansChief Strategy OfficerA100,000$0.00$0.00
Mar 3, 2026Swanson Chad J.Chief Development OfficerA190,000$0.00$0.00
Mar 3, 2026Malecek Michael JChief Legal OfficerA190,000$0.00$0.00
Mar 3, 2026Zago Wagner M.Chief Scientific OfficerA190,000$0.00$0.00
Mar 3, 2026Walker Karin LChief Accounting OfficerA150,000$0.00$0.00
Mar 3, 2026Smith Brandon S.Chief Operating OfficerA190,000$0.00$0.00
Mar 3, 2026Nguyen TranChief Strategy Officer and CFOA230,000$0.00$0.00
Mar 3, 2026Kinney Gene G.President and CEOA520,000$0.00$0.00

No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.

Current analyst consensus: Buy (67% buy). Based on 12 analysts: 2 strong buy, 6 buy, 3 hold, 1 sell, 0 strong sell.

Analyst Price Targets

$21.40 mean target +134.1% upside Strong Buy (2.50)
$8.00 Low $36.00 High
MetricValue
Current Price$9.14
Target Low$8.00
Target Mean$21.40
Target Median$20.00
Target High$36.00
# Analysts5
RecommendationStrong Buy (2.50)

Earnings Estimates & Revisions

PeriodEPS AvgEPS LowEPS HighEPS Growth30d Rev.Up/DownRev. AvgRev. GrowthAnalysts
Current Q
2026-06-30
$0.38 $-0.38 $1.14 122.0% -71.3% 1↑ 0↓ $0.0B -90.4% 2
Next Q
2026-09-30
$-0.30 $-0.37 $-0.23 55.2% -13.2% 1↑ 0↓ $0.0B 297.2% 2
Current FY
2026-12-31
$0.05 $-0.55 $0.65 101.3% -92.2% 2↑ 0↓ $0.1B 760.4% 2
Next FY
2027-12-31
$-1.31 $-1.31 $-1.31 -2720.0% -26.0% 1↑ 0↓ $0.0B -73.6% 1

Current Quarter EPS Revision History

TimepointEPS EstimateChange
Current$0.380
7d ago$1.325-0.945
30d ago$1.325-0.945
60d ago$1.325-0.945
90d ago$1.275-0.895
2 analyst firms have rated this stock: 0 upgrades, 0 downgrades, 0 initiations.

Individual Analyst Actions

DateAnalyst FirmActionPrevious RatingNew Rating
May 8, 2026 Citizens MAINTAIN Market Outperform Market Outperform
Feb 20, 2026 RBC Capital MAINTAIN Sector Perform Sector Perform
Dec 1, 2025 Citizens MAINTAIN Market Outperform Market Outperform

Monthly Consensus History

PeriodStrong BuyBuyHoldSellStrong SellBuy %Distribution
May 1, 20262631067%
Apr 1, 20262631067%
Mar 1, 20262731069%
Feb 1, 20262731069%
Jan 1, 20262731069%
Strong BuyBuyHoldSellStrong Sell

No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.

No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.

May 13, 2026
earnings_calendar
PRTA Q1 2026 Earnings Scheduled — 2026-05-13
May 7, 2026
earnings_calendar
PRTA Q1 2026 Earnings Scheduled — 2026-05-07